Analysis of opioid consumption in clinical trials: a simulation based analysis of power of four approaches
Rasmus Vestergaard Juul(University of Copenhagen), Trine Meldgaard Lund, Ulrika S. H. Simonsson(Uppsala University), Mads Kreilgaard(Lundbeck (Denmark)), Joakim Nyberg(Uppsala University), Lona Louring Christrup(University of Copenhagen)
Cited by 4
Related Papers
Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity <i>in vivo</i>
|Proceedings of the National Academy of Sciences|2003|438
Definition, diagnosis and treatment strategies for opioid-induced bowel dysfunction–Recommendations of the Nordic Working Group
|Scandinavian Journal of Pain|2016|98
Machine Learning and Pharmacometrics for Prediction of Pharmacokinetic Data: Differences, Similarities and Challenges Illustrated with Rifampicin
|Pharmaceutics|2022|92
PopED: An extended, parallelized, nonlinear mixed effects models optimal design tool
|Computer Methods and Programs in Biomedicine|2012|86
Methods and software tools for design evaluation in population pharmacokinetics–pharmacodynamics studies
|British Journal of Clinical Pharmacology|2014|82